Company news

X4 Pharmaceuticals, Inc. news in 2021

X4 Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

X4 Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021

October 24, 2021

X4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial

October 18, 2021

X4 Pharmaceuticals Completes Enrollment in Phase 3 Mavorixafor Trial in Patients with WHIM Syndrome

October 3, 2021

X4 Pharmaceuticals Promotes Mary DiBiase, Ph.D. to Chief Operating Officer

September 7, 2021

X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results

August 2, 2021

X4 Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host a Conference Call and Webcast on August 3, 2021

July 21, 2021

X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021

June 10, 2021

X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia as Published in EHA Abstract

May 11, 2021

X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

May 5, 2021

X4 Pharmaceuticals to Announce First Quarter 2021 Financial Results and Host a Conference Call and Webcast on May 6, 2021

April 21, 2021

X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing

March 18, 2021

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

March 3, 2021

X4 Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call and Webcast on March 4, 2021

February 10, 2021

Calls in 2021

Decks in 2021

  • ASH 2021

    Conference · 8 slides · Dec 16, 2021